Blindness News and Research

RSS

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

The Children’s Tumor Foundation (CTF) has announced a groundbreaking 3-year study, which it will fund for nearly $2 million, to determine if a DNA-based blood test can offer better understanding and ultimately earlier diagnosis of cancer predisposition in neurofibromatosis type 1 (NF1) patients.

16 Dec 2022

Major funding to support studies of the PRPH2 gene linked to macular dystrophy

In healthy vision, a gene called PRPH2 provides instructions to make a protein called peripherin 2 (PRPH2), which plays a key role in the normal functioning of photoreceptors that detect light and color and which line the back of the eye.

16 Dec 2022

The disability tax: Medical bills remain inaccessible for many blind Americans

A Missouri man who is deaf and blind said a medical bill he didn't know existed was sent to debt collections, triggering an 11% rise in his home insurance premiums.

2 Dec 2022

Study shows only 75.8% of children under 15 have antibodies against measles

A study conducted in Brazil and reported in an article in Vaccines shows that in the São José do Rio Preto region in the northwest of São Paulo state, only 75.8% of children aged 0-15 have antibodies against measles.

1 Dec 2022

Newly identified genetic mutation may be a root cause of severe childhood glaucoma

An international team of scientists led by Mass Eye and Ear, a member of Mass General Brigham, and Boston Children's Hospital, has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, a devastating condition that runs in families and can rob children of their vision by 3 years of age.

1 Dec 2022

Scientists discover new potential mechanism for vision loss

Visual cells in the human retina may not simply die in some diseases, but are mechanically transported out of the retina beforehand.

1 Dec 2022

Endogenous system may be responsible for delayed onset of diabetic retinopathy

About one third of patients with diabetes mellitus (DM) develop diabetic retinopathy (DR), a leading cause of blindness in working-age individuals. DR typically develops after many years of DM, and some patients do not develop DR for more than 50 years.

29 Nov 2022

Previously unknown links between genetic factors in ASD identified

In a new study published today in Cell Reports, researchers from the Donald K. Johnson Eye Institute (DKJEI), part of the Krembil Research Institute at University Health Network, have identified previously unknown connections between genetic factors in Autism Spectrum Disorder (ASD).

22 Nov 2022

Repetitive stress induces features of accelerated aging in the eye

New research from the University of California, Irvine, suggests aging is an important component of retinal ganglion cell death in glaucoma, and that novel pathways can be targeted when designing new treatments for glaucoma patients.

21 Nov 2022

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus

8 Nov 2022

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

Johns Hopkins Medicine researchers say they have successfully used a cell's natural process for making proteins to "slide" genetic instructions into a cell and produce critical proteins missing from those cells.

28 Oct 2022

NEI researchers create a high-resolution map of retinal cell chromatin contract points

National Eye Institute researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell's nucleus.

7 Oct 2022

New analysis highlights the need to prioritize addressing preventable vision loss in children in America

An analysis of the nation's first and largest comprehensive eye disease registry, the IRIS® Registry, sheds new light on what we thought we knew about childhood blindness in the United States: The leading causes appear to be retinopathy of prematurity (ROP), nystagmus, and cataract, mostly treatable and preventable causes.

3 Oct 2022

Researchers discover a molecule that promotes tumor cell survival in retinoblastoma

Despite decades of medical advances, children who develop the pediatric eye cancer retinoblastoma often lose their vision or an eye due to a lack of specific, targeted therapies and a poor molecular understanding of the cancer.

3 Oct 2022

IRIS Registry presents latest eye research at AAO 2022

The IRIS Registry (Intelligent Research in Sight) powered several big data studies this year, most of which will be presented and discussed at AAO 2022 Gather, the 126th annual meeting of the American Academy of Ophthalmology.

30 Sep 2022

Research brings us closer to optimizing treatments for children with retinoblastoma

Retinoblastoma is a cancer of the eye that occurs in infants and toddlers and can lead to loss of vision, loss of one or both eyes, and even death.

26 Sep 2022

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

In a new paper, University of California, Irvine researchers explain how precision genome editing agents have enabled precise gene correction and disease rescue in inherited retinal diseases (IRDs).

23 Sep 2022

Researchers uncover a key process involved in diabetes-related vision loss

Researchers at Queen's University Belfast have uncovered a key process that contributes to vision loss and blindness in people with diabetes.

22 Sep 2022

New imaging approach could help accelerate the development of new treatments for eye diseases

Researchers have developed a simple and fast way to perform optoretinography, an imaging technique that measures light-induced functional activity in the eye's retina, the network of neurons in the back of our eyes responsible for detecting light and initiating vision.

22 Sep 2022

Researchers reveal native 3D structure of the ciliary base for the first time

Cilia are small hair-like organelles that extend from cells and perform many functions, including motility and signaling.

19 Sep 2022

Blindness News and Research

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

Major funding to support studies of the PRPH2 gene linked to macular dystrophy

The disability tax: Medical bills remain inaccessible for many blind Americans

Study shows only 75.8% of children under 15 have antibodies against measles

Newly identified genetic mutation may be a root cause of severe childhood glaucoma

Scientists discover new potential mechanism for vision loss

Endogenous system may be responsible for delayed onset of diabetic retinopathy

Previously unknown links between genetic factors in ASD identified

Repetitive stress induces features of accelerated aging in the eye

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

NEI researchers create a high-resolution map of retinal cell chromatin contract points

New analysis highlights the need to prioritize addressing preventable vision loss in children in America

Researchers discover a molecule that promotes tumor cell survival in retinoblastoma

IRIS Registry presents latest eye research at AAO 2022

Research brings us closer to optimizing treatments for children with retinoblastoma

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

Researchers uncover a key process involved in diabetes-related vision loss

New imaging approach could help accelerate the development of new treatments for eye diseases

Researchers reveal native 3D structure of the ciliary base for the first time

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News